Phase 3
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Anemia
Both
Anemia
Trial Information
Inclusion Criteria:
- Body weight >/=99 lbs
- ECOG 0-2
- Anemia results from cancer, chemotherapy, radiotherapy or an association with
hormonal therapy or immunotherapy
- Screening hemoglobin level of
Type of Study:
Interventional
Study Design:
Primary Purpose: Treatment
Authority:
United States: Food and Drug Administration
Study ID:
CR010939
NCT ID:
NCT00083486
Start Date:
February 2004
Completion Date:
October 2004
Related Keywords:
- Anemia
- Anemia
Name | Location |
|---|---|
| Charleston Hematology Oncology | Charleston, South Carolina 29403 |
| Northeast Urology Research | Concord, North Carolina 28025 |
| Mid Ohio Oncology Hematology | Columbus, Ohio 43213 |
| Drexel University College of Medicine | Philadelphia, Pennsylvania 19129 |
| Heritage Physician Group-Oncology | Hot Springs, Arkansas 71913 |
| Spalding Oncology Services | Griffin, Georgia 30224 |
| Southern Illinois Hematology | Centralia, Illinois 62801 |
| BioLab Research | Rockville, Maryland 20852 |
| Slocum-Dickson Medical Group, PC | New Hartford, New York 13413 |
| Caroline Cancer Center | Aiken, South Carolina 29403 |
| Charleston Cancer Care | Charleston, South Carolina 29406 |
| Volunteer Research Group | Knoxville, Tennessee 37920 |
